ArticleBlood2025
MECOM is a master repressor of myeloid differentiation through dose control of CEBPA in acute myeloid leukemia.
Dorien Pastoors et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ArticleBlood2025
Dorien Pastoors et al.PubMed ↗Publisher ↗
No numbers read from the abstract.